Search Press releases Keywords From To 22 May 2007 UCB Presents Long-Term CIMZIA(TM) Data in Crohn's Disease Read More 26 Apr 2007 Statement of the Chief Executive Officer of UCB to the 2007 Annual General Shareholders Meeting Read More 20 Apr 2007 UCB Announces Positive Top-Line Phase III Results for Keppra® as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age Read More 23 Mar 2007 UCB Provides Update on CIMZIA(TM) for Crohn's Disease and Rheumatoid Arthritis in the US Read More 20 Mar 2007 Keppra® Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types Read More 12 Mar 2007 New European Approval for Xyrem® Provides Significant Advance in the Treatment of Narcolepsy Read More Pagination First page Previous page Previous … Page 176 Page 177 Page 178 Page 179 Current page 180 Page 181 Page 182 Page 183 Page 184 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
